George Retsch-Bogart

Professor of Pediatrics

University of North Carolina at Chapel Hill School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

George Retsch-Bogart is a Professor of Pediatrics at the University of North Carolina at Chapel Hill School of Medicine in the United States. His research focuses on cystic fibrosis, particularly the impact of therapies like azithromycin and tobramycin, as well as lung disease progression and clinical trial methodologies. He has published extensively on topics such as the effects of SARS-CoV-2 on cystic fibrosis therapeutic development and the evaluation of chronic therapy cessation after modulator drug therapy.

Articles (9)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Christopher Goss

Professor of Medicine and Pediatrics

University of Washington

UNITED STATES

View details

Alex Gifford

Associate Professor

University Hospital

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

George Retsch-Bogart

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new Pseudomonas

Testing the effects of combining azithromycin with inhaled tobramycin for <i>P. aeruginosa</i> in cystic fibrosis: a randomised, controlled clinical trial

A new path for CF clinical trials through the use of historical controls

Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Study Design.

Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis

The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.

Building global development strategies for cf therapeutics during a transitional cftr modulator era.

Changes in the parent cystic fibrosis questionnaire-revised (CFQ-R) with respiratory symptoms in preschool children with cystic fibrosis

The utility of moment ratios and abbreviated endpoints of the multiple breath washout test in preschool children with cystic fibrosis

Collaborators (2)

Christopher Goss

Alex Gifford

Make your next move.